NCT06720831 Role of Mesh in Laparoscopic Sacropexy Surgical Techniques for the Treatment of Female Genital Prolapse
| NCT ID | NCT06720831 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Female Genital Prolapse |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-12 |
| Primary Completion | 2025-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2024-12 with a primary completion date of 2025-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the rate of recurrence of central pelvic organ prolapse in patients who have undergone surgery (sacropexy with and without mesh) for the same pathology.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Clinical diagnosis of genital prolapse stage ≥ 2 according to POP-Q classification * Surgical treatment of laparoscopic sacropexy by mesh (group 1) and without (group 2) in female patients * Acquisition of informed consent * At least one follow-up evaluation at 24 months Exclusion Criteria: * Age \> 80 years * Previous genital prolapse surgery
Contact & Investigator
Diego Raimondo, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06720831 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Female Genital Prolapse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06720831 currently recruiting?
Yes, NCT06720831 is actively recruiting participants. Contact the research team at die.raimondo@gmail.com for enrollment information.
Where is the NCT06720831 trial being conducted?
This trial is being conducted at Bologna, Italy, Verona, Italy.
Who is sponsoring the NCT06720831 clinical trial?
NCT06720831 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Diego Raimondo, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 160 participants.